Canada· CA-DIN-02537680
ACTIVATED CHARCOAL CAPSULES
A medicinal charcoal product containing charcoal activated, registered in Canada by BIOCLINIC NATURALS INC.. The same ATC class is registered in 12 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Medicinal charcoal is registered in 12 of 19 countries.
Countries holding a registration under ATC A07BA01 (medicinal charcoal), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 8 of them publish a price we can compare per daily dose
Medicinal charcoal · ATC A07BA01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- CHARCOAL ACTIVATED
- Manufacturer
- BIOCLINIC NATURALS INC.
- Country
- Canada (CA)
- ATC code
- A07BA01
- ATC class
- Medicinal charcoal
- Defined daily dose
- 5 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
85 interactions on record for medicinal charcoal.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Medicinal charcoal · interactions on record
85 records
- 1 severe
- 82 moderate
- 2 minor
Most severe, free to view
- Mycophenolic acidL04AA06severe
- NizatidineA02BA04moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Medicinal charcoal in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesACTIDOSEPadagis US LLC
- BelgiumCarbo Vegetabilis Boiron 15CHBoiron
- United KingdomActidose-Aqua Advance 1.04g/5ml oral suspensionAlliance Pharmaceuticals Ltd
- FinlandBISMUTHUM Alfaplex (Al 8)
- FranceACTICARBINE 70 mg, comprimé enrobéELERTE
- PolandCarbo Activ AflofarmAflofarm Farmacja Polska Sp. z o.o.
- Japan球形吸着炭日医工
- NetherlandsCarbo vegetabilisBoiron
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Iceland · Kolsuspension
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe713044-da68-4064-9eb2-c715976d8a47 GET /v1/drugs/fe713044-da68-4064-9eb2-c715976d8a47?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02537680",
"form": "CAPSULE",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "A07BA01",
"schedule": [
"OTC"
],
"drug_code": "102646",
"strengths": [
"250 MG"
],
"ahfs_class": null,
"substances": [
"CHARCOAL ACTIVATED"
],
"product_categorization": "LS - ANTIFLATULENTS"
}See everything about medicinal charcoal.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.